Resource Filter: Mouse
WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule, Induces a Strong Anti-tumor Phenotype Through a Differentiated Mechanism
Date
Discovery of WTX-518, an IL-18 Pro-drug That is Conditionally Activated Within the Tumor Microenvironment and Induces Regressions in Mouse Tumor Models
Date
Spotiflow: accurate and efÏcient spot detection for imaging-based spatial transcriptomics with stereographic flow regression
Date
Spatial Analysis of Tumor Infiltrating Lymphocyte Populations in Syngeneic Mouse Tumor Models After Treatment with IL-12 (mWTX-330) or IL-2 (WTX-124) INDUKINE™ Molecules
Date
The Combination of ACT and INDUKINE™ Therapy Leads to Improved Antitumor Immunity in Mouse Solid Tumors
Date
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Date
Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment
Date
A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides
Date
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Date
Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics
Date